The New York Academy of Sciences is proud to present Molecular Pathways and Cellular Players in the Resolution of Organ Fibrosis.
Organ fibrosis is a critical challenge across multiple diseases, where unchecked scarring disrupts tissue architecture and function. Yet, recent advances in multiomics, mechanobiology, and therapeutic innovation are shedding light on the cellular and molecular mechanisms that may allow fibrosis to be reversed, or even prevented. While significant progress has been made in dissecting the mechanisms of fibrotic progression in tissues, key challenges remain in understanding the resolution and reversal of organ fibrosis.
This one-day symposium will bring together leading experts from academia, industry, and clinical research to explore the biology of fibrosis, emerging multiomic insights, and the development of targeted therapies and biomarkers. Conference topics will encompass the biology of fibrosis, multi-omics signatures, target identification, therapeutics, and imaging biomarkers, among other areas. Researchers at all career stages are invited to join us in accelerating discovery, building meaningful collaborations, and engaging in conversations that will shape the future of fibrosis science.
